Quality of life and functional outcome of rectal cancer patients: A prospective cohort study.
Alexander J Pennings, Geraldine R Vink, Sander van Kuijk...
https://pubmed.ncbi.nlm.nih.gov/39358881/Actively Recruiting
Led by Dutch Colorectal Cancer Group · Updated on 2026-06-04
50000
Participants Needed
70
Research Sites
52 weeks
Total Duration
Researchers are investigating how various factors beyond tumor stage, such as biochemical, histopathological, genomic, environmental, and clinical characteristics, affect the outcomes of patients diagnosed with colorectal cancer CRC, small bowel cancer, and anal cancer. This observational study aims to collect detailed information from diagnosis through long-term follow-up to better understand prognosis and treatment effects in both early and late-stage cancers. The study addresses the gap between clinical trial populations and real-world patients by including a broader patient group treated in general practice. Participants will be followed prospectively from their initial diagnosis until death. Data collection includes medical history, clinical parameters, imaging, pathology, tumor details, treatments, hospital stays, interventions, and adverse events. With separate consent, patient-reported quality of life and work ability information will also be gathered. Additionally, biological samples obtained during routine care may be collected for further observational and molecular research. This cohort serves as a platform for evaluating new interventions through a Trials within Cohorts TwiCs design. Throughout up to ten years of follow-up, participants will undergo assessments of progression-free survival, disease-free survival, overall survival, and serious adverse events. Quality of life and work ability are assessed at intervals of 3, 6, 12, 24, 36, and 48 months. This extensive data collection supports a wide range of research aims including prognostic studies, molecular analyses, comparisons of new treatments, and health policy evaluations. The study provides a comprehensive view of treatment outcomes and patient experiences in everyday clinical settings.
CONDITIONS
Prospective Data Collection Initiative on Colorectal Cancer
M
Miriam Koopman, MD, PhD
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Dutch Colorectal Cancer Group
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Up to 10 years
Participants are observed from their primary diagnosis until death, with data collected on medical history, treatments, outcomes, and quality of life.
Visits at 3, 6, 12, 24, 36, and 48 months with additional long-term follow-up
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Have more questions? Get in touch with our team for quick support
Alexander J Pennings, Geraldine R Vink, Sander van Kuijk...
https://pubmed.ncbi.nlm.nih.gov/39358881/Anne-Sophie van Lanen, Dieuwertje E Kok, Evertine Wesselink...
https://pubmed.ncbi.nlm.nih.gov/38700376/Karel C Smit, Jeroen W G Derksen, Rebecca K Stellato...
https://pubmed.ncbi.nlm.nih.gov/38079324/Dutch Colorectal Cancer Group
Lead Sponsor